DexCom vs Insulet: Which Diabetes Stock Is Best in 2026
DexCom and Insulet sit at the heart of diabetes technology. This in-depth look examines growth drivers, financials, a...
Explore when to make changes to your spending plan and how to rebalance categories so you stay aligned with goals and cash flow.
23,566 articlesDexCom and Insulet sit at the heart of diabetes technology. This in-depth look examines growth drivers, financials, a...
VUG, Vanguard’s Growth ETF, with about $223B in assets, is outperforming many active large-cap funds while charging j...
A $10,000 investment in Asia’s biggest stocks grew to $15,267 by June 3, 2026, outpacing most U.S. large caps and hig...
Bitcoin hits $64,000 as a viral altcoin skyrockets daily sends shockwaves through the market. Traders weigh liquidity...
A coalition of over 200 crypto firms is pressing Congress for a floor vote on the CLARITY Act, warning that time is r...
Cardano's on-chain indicators show unusual activity as ADA slides in a broader market sell-off and Charles Hoskinson ...
A new release from Anthropic is triggering a global debate over hidden safeguards. Critics say Claude Fable 5 quietly...
Forgotten DeFi contracts lingering on-chain pose a fresh risk. The next defi drain could hinge on legacy pools and re...
A veteran investor argues Talen Energy is undervalued versus its replacement cost, with potential for a doubling or m...
With July 4 as a symbolic deadline, experts warn the CLARITY Act faces a difficult path through a divided Senate. Thi...
A wave of state laws on private listings in housing is reshaping how loans and mortgages are marketed. Three regulato...
Former BitMEX CEO Arthur Hayes appears to be adding more ETH as critics circle over recent token hype and sales. Look...